ABSTRACT
Vision loss in neovascular age-related macular degeneration (ARMD) results from abnormal tissue disturbing underlying supporting structures of the retina: the retinal pigment epithelium (RPE), Bruch’s membrane, and the choriocapillaris. Macular translocation surgery is a procedure used to arrest vision loss and in some cases improve vision by rotating the fovea away from the underlying diseased structures to an area of healthy RPE and underlying tissue. The retina was detached via a transscleral approach and the retinal rotation and reattachment was achieved using silicone oil rather than an intervening step of perfluorocarbon liquid infusion prior to silicone oil placement. With the retina free of any peripheral attachments such as bridging vitreous strands, the translocation proceeds. Many current treatment modalities are designed to slow the progression of vision loss and recover vision in patients with neovascular ARMD.
